Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

PHARMOBEDIENT

  • FDA Approval
  • Oct. 29, 2025, 18:02 UTC
  • 22
  • 0 comments

FDA approve ATROPINE SULFATE; EDROPHONIUM CHLORIDE

Comment Full text

PHARMOBEDIENT

  • FDA Approval
  • Oct. 29, 2025, 18:02 UTC
  • 22
  • 0 comments

FDA approve ATROPINE SULFATE; EDROPHONIUM CHLORIDE

Comment Full text

CHANGZHOU PHARM

  • FDA Approval
  • Oct. 29, 2025, 08:47 UTC
  • 26
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

MSN

  • FDA Approval
  • Oct. 29, 2025, 08:47 UTC
  • 30
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

SANDOZ

  • FDA Approval
  • Oct. 29, 2025, 08:47 UTC
  • 26
  • 0 comments

FDA approve ANASTROZOLE

Comment Full text

AZURITY

  • FDA Approval
  • Oct. 28, 2025, 15:49 UTC
  • 20
  • 0 comments

FDA approve CABOZANTINIB

Comment Full text

CHARTWELL

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 17
  • 0 comments

FDA approve ACETAMINOPHEN; HYDROCODONE BITARTRATE

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 19
  • 0 comments

FDA approve ATROPINE SULFATE

Comment Full text

DR REDDYS

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 18
  • 0 comments

FDA approve DOCOSANOL

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 21
  • 0 comments

FDA approve ANASTROZOLE

Comment Full text
  • Previous
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next

Search

News categories

  • Technical Exchange News(10560)
  • Event(1905)
  • SEC News(183068)
  • FDA Approval(9791)
  • Company Report(721)
  • Business News(121454)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin